Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1833358320941190 http://scihub22266oqcxt.onion/10.1177/1833358320941190 32680440!?!32680440 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32680440&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Health+Inf+Manag 2021 ; 50 (1-2): 9-12 Nephropedia Template TP {{tp|p=32680440|t=2021. A false promise of COVID-19 big health data? Health data integrity and the ethics and realities of Australia s health information management practice |pdf=|usr=}}{{32680440}} gab.com Text A false promise of COVID-19 big health data Health data integrity and the ethics and realities of Australia s health information management practice JO: Health Inf Manag http://www.kidney.de/pget.php?&tw=1&pmid=32680440 #FOAvip Context: Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated an unprecedented volume of medical research. Articles reporting two studies were recently retracted from prestigious journals for reasons including the (thus far) unverifiable provenance of data. This commentary adopts a health information management lens to focus on aspects of data in one of the studies (investigating the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19). The issues: Referencing the Australian context, the current article considers some of the study's reported hospital administrative and coded data categories within the context of Australian hospitals' health information management practices. It highlights potential risks associated with the collection and interpretation of 'big' health data. Implications: This article identifies pitfalls that confront researchers undertaking multi-country studies and the need to consider country-specific: (i) collected administrative data items; (ii) health information-related ethical, legal and management policy constraints on the use of confidential hospital records and derived data; and (iii) differences in health classification systems and versions used in the coding of diagnoses and related procedures, interventions and health behaviours. Conclusions: The article concludes that the inclusion of a qualified, senior Health Information Manager in research teams and on institutional Human Research Ethics Committees would help to prevent potential problems. Twit Text FOAVip A false promise of COVID-19 big health data Health data integrity and the ethics and realities of Australia s health information management practice ????Health Inf Manag http://www.kidney.de/pget.php?&tw=1&pmid=32680440 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32680440 #FOAvip English Wikipedia <ref>{{Cite pmid|32680440}}</ref> A false promise of COVID-19 big health data? Health data integrity and the ethics and realities of Australia s health information management practice #MMPMID32680440 Robinson K Health Inf Manag 2021[Jan]; 50 (1-2): 9-12 PMID32680440show ga Context: Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated an unprecedented volume of medical research. Articles reporting two studies were recently retracted from prestigious journals for reasons including the (thus far) unverifiable provenance of data. This commentary adopts a health information management lens to focus on aspects of data in one of the studies (investigating the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19). The issues: Referencing the Australian context, the current article considers some of the study's reported hospital administrative and coded data categories within the context of Australian hospitals' health information management practices. It highlights potential risks associated with the collection and interpretation of 'big' health data. Implications: This article identifies pitfalls that confront researchers undertaking multi-country studies and the need to consider country-specific: (i) collected administrative data items; (ii) health information-related ethical, legal and management policy constraints on the use of confidential hospital records and derived data; and (iii) differences in health classification systems and versions used in the coding of diagnoses and related procedures, interventions and health behaviours. Conclusions: The article concludes that the inclusion of a qualified, senior Health Information Manager in research teams and on institutional Human Research Ethics Committees would help to prevent potential problems. |*Big Data[MESH] |*COVID-19 Drug Treatment[MESH] |Access to Information[MESH] |Administrative Personnel[MESH] |Australia[MESH] |Bioethics[MESH] |Computer Security[MESH] |Data Interpretation, Statistical[MESH] |Electronic Health Records[MESH] |Health Information Management/*ethics/legislation & jurisprudence[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Privacy[MESH] |Research[MESH]A false promise of COVID-19 big health data? Health data integrity a(epmc).pdf DeepDyve Pubget Overpricing